Loading...

Ipsen S.A.

IPSEY•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$49.15
$0.61(1.26%)
U.S. Market opens in 14h 23m

Ipsen S.A. (IPSEY) Stock Overview

Explore Ipsen S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap65B
P/E Ratio30.92
EPS (TTM)$1.55
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$44.34
3 Months$46.57
1 Year Target$38.88

IPSEY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ipsen S.A. (IPSEY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 75.93, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $38.88.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.92 and a market capitalization of 65B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.26%
5-Day Change
1.26%
1-Month Change
11.98%
3-Month Change
25.70%
6-Month Change
49.17%
Year-to-Date (YTD) Change
35.18%
1-Year Change
73.55%
3-Year Change
73.31%
5-Year Change
117.57%
All-Time (Max) Change
455.37%

Contact Information

https://www.ipsen.com
33 1 58 33 50 00
65 Quai Georges Gorse, Boulogne-Billancourt, NaN, 92100

Company Facts

5,358 Employees
IPO DateAug 3, 2012
CountryFR
Actively Trading

Frequently Asked Questions